ipilimumab Injection

Brand(s)
Yervoy
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
E.R. Squibb & Sons, L.L.C. (2015-10-28)
Oldest Current Product
2011-03-25
License(s)
BLA
RxNORM
INJECTION\IPILIMUMAB
SPL Active
INTRAVENOUS\INJECTION\IPILIMUMAB
SPL Moiety
INTRAVENOUS\INJECTION\IPILIMUMAB

product(s) by strength(s)

10 ml ipilimumab 5 mg/ml injection

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1000032327YervoyBLAE.R. Squibb & Sons, L.L.C.2011-03-25IPILIMUMABINTRAVENOUSINJECTION1253772265ef30-253e-11df-8a39-0800200c9a66

40 ml ipilimumab 5 mg/ml injection

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1000032328YervoyBLAE.R. Squibb & Sons, L.L.C.2011-03-25IPILIMUMABINTRAVENOUSINJECTION1253772265ef30-253e-11df-8a39-0800200c9a66

application(s)

#idtitleapprovedtradenamesfda division
1125377ipilimumab Application2011-03-25YervoyCDER

spl(s)

#idtitlecategorytypelabelerlast updateversionproduct(s)
12265ef30-253e-11df-8a39-0800200c9a66 (view SPL)These highlights do not include all the information needed to use YERVOY safely and effectively. See full prescribing information for YERVOY. YERVOY (ipilimumab) injection, for intravenous use Initial U.S. Approval: 2011prescriptionHuman PrescriptionE.R. Squibb & Sons, L.L.C.2015-10-2812000032327, 000032328

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII